Mint Venture Partners

SanaHeal provider of a bioadhesive tape designed to bind to tissues or organs

Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics, and machine learning to enhance a surgeon’s intra-operative decision making, and reduce unintended and preventable surgical complications. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Alzheimer’s Disease is one of the most prevalent neurodegenerative diseases causing insufferable pain to patients and their families. There are over 55 million people worldwide living with dementia, and Alzheimer’s Disease is the most common form of dementia. Unfortunately, the aging population will only exacerbate the prevalence of the disease, yielding immense medical costs in addition to the already devastating social burden. At BeauBrain Healthcare, we are revolutionizing the current treatment paradigm from “post-diagnosis treatment” to “pre-emptive intervention.” Our solutions enable early identification of the disease through predictive analysis of disease-specific biomarkers (Amyloid Beta, Tau, Neurodegeneration), and a personalized cognitive training platform (DTx). Ultimately, our long-term vision is to realize precision medicine for Alzheimer’s disease through the biomarker data generated from our diverse solutions combined with a vast amount of genetic data.

Seawith is a biotechnology startup developing cell-cultured steak from seaweed. Yo.od, a low-iodine seaweed developed by Seawith, is aimed at consumers with low iodine resistance and high iodine sensitivity. Seawith creates its own culture media from microalgae, which provides the benefits of algae nutrition while also being much cheaper due to the abundance of microalgae.

Organoid Sciences is an organoid-based treatment drug development company that offers drug screening and regenerative medicines.

Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on.

GenoTwin’s core mission is to weave the power of genomics into the public health fabric by providing powerful and practical solutions to the world's pressing infectious disease challenges. Our innovative genomics platform combines cutting-edge capabilities in genomics, AI, and computational biology to support clinicians, public health officials, and researchers in four key areas: Pathogen Detection; Pathogen Surveillance; Immune/Resistance Assessment; and Precision Treatment.

Key Proteo is a developer of a novel peptide screening for newborn babies. The company aims to improve and expand the current newborn screening programs and subsequently provide early intervention for genetic diseases before they are clinically manifested. It specializes in multiplex analysis for any extremely low-abundance proteins from a few drops of blood (DBS) using surrogate peptide markers by mass spectrometry. With this new technology, Key Proteo targets new or existing genetic conditions to change their clinical course and ensure a better quality of life for its patients.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligence, analytics, and machine learning to enhance a surgeon’s intra-operative decision making, and reduce unintended and preventable surgical complications. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.

MEZOO is a medical device manufacturing company.

NEXTON specializes in agricultural product cultivation and food sales. It is an indoor vertical farm startup in Korea which naturally maintains temperatures of 10-20C throughout the year even without active heating or cooling solutions. The company is hydroponically growing leafy greens and others without pesticide or herbicide with nutrient water fully-recycled and disinfected chemical-free. Its products include leafy greens, Korean strawberries, pharmaceutical plants, and cosmetics.

Hyperfine is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared point-of-care MRI system. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a low magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.